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needling is haemorrhage – either 
sub-conjunctivally or into the anterior 
chamber. If your view is obscured, then 
you should stop and try another time. 
A hyphaema requires the patient to be 
reassured, as their vision will be affected: 
you should wait until you are sure the 
active bleeding has stopped. Let the 
patient rest for 30–60 minutes then 
check for ongoing haemorrhage and a 
pressure rise, since the blood can 
sometime obstruct drainage completely. 
Once stable, manage the patient as for a 
hyphaema post-trabeculectomy: 
discharge the patient and review within 
one week as appropriate.
The other post-needling complication 
is hypotony. I personally have only had to 
take one patient back to theatre for this to 
date. If the anterior chamber has signifi -
cantly shallowed, let the patient rest and 
see if it reforms spontaneously. If it does, 
then manage the patient as for a low 
pressure following trabeculectomy. If it 
does not, then introducing viscoelastic or 
gas to the anterior chamber is your best 
option, with regular review as appropriate. 
Case reports exist of infection and 
mis-placed needles, but these are fortu-
nately rare (hopefully because appropriate 
care has been taken by clinicians). 
Prophylactic topical antibiotics are used 
by most practitioners. Pre- and post-
operative steroids remain a mainstay of 
therapy to prevent recurrent scarring. 
Sub-conjunctival steroid and 5-fl uor-
ouracil (5FU) are the most common 
antiscarring preparations. Be extremely 
careful that the drugs do not enter the 
anterior chamber. If they do, wash out in 
theatre immediately. See page 75 for 
tips on administration of 5FU. Mitomycin 
C is being used more frequently, and 
interferon, sodium hyaluronate, and 
bevacizumab are amongst the many 
additional agents that have been 
reported, with varying success. 
If needling is not appropriate or has 
failed, what subsequent procedure is 
required?
This depends on all the above factors and 
what is possible in your unit. Cyclodiode 
ciliary body ablation, repeat trabecu-
lectomy at a second site, formal revision 
of the existing trabeculectomy, and 
drainage tube implantation are the most 
common options.
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Most guidelines that exist for the treatment 
of primary open-angle glaucoma (POAG) – 
such the National Institute for Health and 
Clinical Excellence (NICE) guidelines 
(page 47) – recommend 
medicine as initial 
therapy, though laser 
treatment may also play a 
role. 
None of these guide-
lines are based on 
research done in Africa, 
however, and there also 
is no evidence yet on the 
relative effectiveness of different glaucoma 
medications in African populations.
For medicines to be effective at 
controlling POAG, they must be used 
every day for the remainder of the 
patient’s life.
This means the medicine must not only 
be clinically effective, it must also be 
available, of good quality, affordable, and 
well tolerated by the patient. 
Keep the following in mind when 
choosing medical treatment for your 
patient.
1 the cost: can the patient afford the 
recommended medication in the long 
term? 
2 availability: will the drug(s) always be 
in stock, and what are the conse-
quences to the patient of any 
stock-outs? 
3 Quality: for drugs such as latanoprost, 
will the cold chain be maintained? Can 
the patient refrigerate the medicine? 
Can the patient 
recognise and avoid 
fake drugs?
4 Discomfort: is there 
any discomfort 
associated with the 
medicine that will 
discourage the 
patient from 
continuing with 
treatment?
5 Follow-up: will the 
patient be able to 
attend regular 
follow-up appoint-
ments?
If you have concerns about any of the 
above, it may be advisable to consider 
surgery to control intraocular pressure (IOP).
Ongoing monitoring is essential during 
medical treatment. The 
NICE guidelines suggest 
that surgery should be 
offered if two drugs (or 
one fi xed-combination 
drug preparation) are not 
suffi cient to control 
pressure and/or halt 
disease progression.
choosing	the	right	drugs
There are five main groups of glaucoma 
drugs, each acting in a different way to 
reduce IOP:
•	prostaglandin analogues 
(bimatoprost, latanoprost, and 
travoprost) increase uveoscleral outflow
•	beta-blockers consist of two main 
groups: selective (betaxolol) and 
non-selective (timolol, levobunolol), 
both of which decrease aqueous 
production
•	alpha-2 adrenergic agonists 
(apraclonidine, brimonidine) decrease 
aqueous production and increase 
uveoscleral outflow
•	carbonic anhydrase inhibitors 
decrease aqueous formation and can 
be applied topically (brinzolamide, 
dorzolamide), or systemically 
(acetazolamide, methazolamide)
•	parasympathomimetics (pilocarpine, 
carbachol) increases aqueous outflow 
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through the trabecular meshwork by 
means of ciliary muscle contraction, 
and may open the drainage angle in 
angle-closure glaucoma by stimulating 
the iris sphincter muscle.
Generally, the recommended first-line 
drug will be one of the prostaglandin 
analogues (e.g., latanaprost). These 
drugs have an IOP lowering effect of 
28–33%, require once a day dosing, and 
have limited local side effects. However, 
they are expensive and can be difficult 
to obtain. 
Timolol, a beta-blocker, is cheaper and 
quite effective (an IOP lowering effect of 
20–30%), but it has systemic side 
effects: it worsens obstructive pulmonary 
diseases, slows heart rate, and lowers 
blood pressure. Timolol 0.5% is no more 
effective than 0.25% is, but is much more 
likely to cause side effects. 
If patients require more than one type 
of medication, use fixed combination drug 
preparations rather than two separate 
bottles. There is no evidence that fixed 
combinations have better outcomes than 
using individual drugs. However, using 
fixed combinations is more convenient, 
reduces the amount of preservatives that 
enter the eye, and may make it more 
likely that patients will continue with their 
treatment (known as adherence or 
compliance). 
It is not advisable to use two or more 
combinations in an eye. As mentioned 
before, if a single combination does not 
work, NICE guidelines recommend 
offering surgery to the patient.
Side	effects
Each drug has different side effects, so 
prescribers and patients are advised to 
read inserted leaflets carefully. 
•	Pregnant women should avoid 
prostaglandin analogues (which can 
cause uterine contractions) and 
carbonic anhydrase inhibitors (which 
have teratogenic effects).
•	People with asthma should avoid 
beta-blockers and parasympathomimetics 
(which can cause bronchiospasm).
•	People with sickle-cell anaemia and/
or kidney and liver disease should 
avoid carbonic anhydrase inhibitors.
•	People with heart block which is 
greater than first degree, and anyone 
with chronic obstructive pulmonary 
disease and sinus brachycardia 
should avoid beta-blockers. 
useful	hints
1 Determine a target IOP before starting 
treatment. IOP with initial single-drug 
therapy should be reduced by at least 
20% from baseline. IOP reduction of 
less than 10% should be considered as 
a non-response.
2 The treatment goal should include 
stable optic nerve and nerve fibre layer 
status, as well as stable visual fields. 
3 Switching drugs within the prostagland-
in analogue class may, upon occasion, 
provide greater lowering of IOP.
4 Pilocarpine is useful in pigmentary 
glaucoma (PG) and pseudoexfoliation 
glaucoma (PXG), as it reduces iris 
movements. It may therefore reduce 
deposition of exfoliation material or 
pigment in the trabecular meshwork. 
5 Topical carbonic anhydrase inhibitors 
(CAIs) and systemic CAIs are poorly 
additive with respect to lowering IOP.
6 Numerous studies have demonstrated 
neuroprotection in experimental 
models of glaucoma or optic nerve 
injury, but good evidence demon-
strating neuroprotection in clinical 
studies is lacking. 
7 There is insufficient evidence for neuro-
protection by alpha-2 adrenergic 
agonists in humans. 
Patient’s	adherence	to	treatment	
may	be	encouraged	and	monitored	by:
•	Educating and counselling the patient
•	Training personnel to teach patients and 
their carers
•	Explaining the possible side effects of 
each drug
•	Teaching the patient to record the drugs 
used and instilled (page 79)
•	Checking the patient’s drugs at each 
clinic visit
•	Prescribing combination drug 
preparations, where available, rather 
than many single preparations
•	Giving advice to patients on how to instil 
eyedrops, particularly if they have any 
physical impairments, including visual 
impairment.
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•	Buy drugs from registered 
pharmacies
•	Look out for the national drug 
administration/agency licensing 
number in your country.
•	Check the manufacturing and expiry 
dates of drugs and be sure that these 
have not been altered on the packet.
•	Many companies now have 
holograms of their logos on the 
packet, look for that.
•	Some drug companies provide a 
means for patients to check the 
authenticity of their medicines. For 
example, many drug companies in 
Nigeria put a unique code or number 
on each box or bottle. Patients can 
SMS this free of charge to the phone 
number provided and the 
drug company will confirm 
whether the drug is 
registered and therefore 
genuine. This facility 
should be used where 
available
•	Do not buy drugs from 
hawkers. Apart from 
raising doubts about the 
drug’s authenticity, 
hawkers will not be able to 
store the drugs in the 
correct conditions. Poor 
storage, heat, and 
sunshine will decrease 
the potency.
•	Never accept any drug 
package without a 
company label from the manufacturer 
(some people peel off the label and 
write the dosage on the bottle to hide 
the identity of the medication).
•	If not sure of your medication, bring it 
to the hospital for it to be checked 
and confirmed.
•	Be careful with expensive imported 
brands from big, well-known drug 
companies; they are more likely to be 
fake than locally produced drugs from 
smaller companies
•	Ideally, eye care facilities should 
stock genuine drugs in good 
quantities and at reasonable prices.
This will help ensure that patients 
have access to the medicines they 
need from a trusted source.
How to avoid fake glaucoma drugs: top tips
It is vital to educate patients about fake drugs 
and how to avoid them. Fake drugs waste money 
and can cost patients their sight. NIGERIA
Fa
tim
a 
Ky
ar
ii
© The author/s and Community Eye Health Journal 2012. This is an Open Access article distributed under the Creative Commons Attribution Non-Commercial License.
CEHJ79_FINAL4_OA.indd   78 01/02/2013   11:48
•	If you have just been prescribed eye drops, make sure 
someone has shown you how to instil them. Do not 
leave the eye clinic until you know what to do. Make 
sure you have had time to practice under supervision. 
•	Keep this handout safe for future reference.
•	Instilling your own eye drops is not easy at first, but your 
skill will develop as you practice. You will find a 
technique that works well for you but there are some 
points that are very important (shown in bold).
•	If, after much practice, you are still struggling, ask a 
family member or carer to instil the eye drops for you.
•	You may think it will help to use a mirror and some 
people may even advise this. In fact, the use of a mirror 
only complicates matters and can even create a 
dangerous technique. Avoid the use of a mirror!
•	Eye drops are dispensed in various containers: a bottle 
(plastic or glass) with a removable dropper and 
combined cap; a plastic bottle with dropper attached and 
removable cap ; or a glass bottle with plastic pipette 
attachment and removable cap. Whatever type is given to 
you, do not touch the part from which the drop falls. 
•	Before instilling eye drops, wash your hands thoroughly, 
and afterwards too.
How	to	instil	your	own	eye	drops
1 Sit or lie down with your head supported. 
As your skill develops you may eventually manage to 
instil your eye drops while standing.
2 Use your dominant hand to hold the bottle/dropper/pipette 
3 With the index finger of your other hand, hold a clean 
piece of tissue or cotton wool, and gently pull down 
the lower eyelid to form a ‘pocket’.
4 Hold the bottle/dropper/pipette between your thumb 
and forefinger, and place the ‘heel’ of your hand (where 
the wrist meets the hand) on your cheek. This will help 
to steady shaky hands. 
5 Make sure there is a distance of about an inch (2.5 
cm) between your eye and the end of the bottle/
dropper/pipette. Be careful – the tip must not touch 
any part of the eye or eyelids.
6 Look up or to the side. Do not look directly at the 
bottle/dropper/pipette.
7 Squeeze the bottle/dropper/pipette – allow one drop 
to fall into the lid pocket.
8 Slowly let go of the lower lid. Gently close your eyes; 
try not to shut them tightly as this will squeeze the 
drop out of your eye.
9 Dab your closed eye with the tissue or cotton wool to 
remove any excess. 
10 Put gentle pressure on the inside corner of your eye 
and count to 60, very slowly. This prevents the 
medicine from draining out of your eye before it is 
absorbed.
INSTRucTIONS	FOR	PaTIENTS
Instilling your own eye drops
medication Eye (left eye, 
right eye, both 
eyes?)
Breakfast/
sunrise
lunch/midday Evening/sunset Bedtime
Table 1. Sample patient record of eye drops instilled, for someone who has to instil eye drops four times a day.
general
•	Store eye drops in a cold place, if possible in a 
refrigerator. It easier to feel a cold drop going in; this 
will reassure you that your technique is good.
•	If you struggle to hold a small bottle/dropper/pipette, 
wrap something like a folded piece of tissue around it
•	Wait at least 5 minutes between inserting different 
types of eye drops.
•	Instil eye drops first, then eye ointment (if prescribed).
glaucoma	patients
•	Instil your drops at regular intervals throughout the 
day. This is vital in controlling the intraocular pressure. 
•	Create a form or ‘tick sheet’ you can fill in when you 
have taken your drops (see Table 1). 
•	It is important to learn to instil your 
own drops. Medication for glaucoma is usually 
needed for the long term.
•	Practice makes perfect!
A few more top tips
Everybody develops their 
own technique that works 
for them
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